Insufficient scRNA-seq data for expression of PLA2G4E at single-cell level.
Insufficient scRNA-seq data for expression of PLA2G4E at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 28% | 576.55 | 402 / 1445 | 57% | 12.55 | 105 / 183 |
tonsil | 0% | 0 | 0 / 0 | 84% | 8.31 | 38 / 45 |
skin | 72% | 8148.36 | 1295 / 1809 | 11% | 1.65 | 50 / 472 |
lung | 17% | 77.11 | 98 / 578 | 50% | 3.31 | 577 / 1155 |
uterus | 1% | 14.42 | 2 / 170 | 43% | 7.83 | 196 / 459 |
bladder | 0% | 0 | 0 / 21 | 20% | 2.43 | 103 / 504 |
muscle | 13% | 37.72 | 105 / 803 | 0% | 0 | 0 / 0 |
stomach | 0% | 0 | 0 / 359 | 10% | 0.44 | 30 / 286 |
prostate | 3% | 7.14 | 7 / 245 | 6% | 0.13 | 29 / 502 |
intestine | 0% | 0.39 | 2 / 966 | 7% | 0.31 | 37 / 527 |
adrenal gland | 3% | 10.57 | 8 / 258 | 0% | 0.01 | 1 / 230 |
breast | 0% | 0 | 0 / 459 | 3% | 0.17 | 36 / 1118 |
liver | 2% | 5.03 | 5 / 226 | 1% | 0.01 | 3 / 406 |
pancreas | 0% | 0 | 0 / 328 | 3% | 0.19 | 5 / 178 |
heart | 1% | 2.14 | 6 / 861 | 0% | 0 | 0 / 0 |
thymus | 0% | 0 | 0 / 653 | 0% | 0.01 | 3 / 605 |
adipose | 0% | 14.44 | 3 / 1204 | 0% | 0 | 0 / 0 |
ovary | 0% | 0 | 0 / 180 | 0% | 0.00 | 1 / 430 |
blood vessel | 0% | 4.02 | 3 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0.36 | 2 / 929 | 0% | 0 | 0 / 0 |
kidney | 0% | 0 | 0 / 89 | 0% | 0.00 | 1 / 901 |
brain | 0% | 0.29 | 2 / 2642 | 0% | 0 | 0 / 705 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0036149 | Biological process | phosphatidylinositol acyl-chain remodeling |
GO_0046475 | Biological process | glycerophospholipid catabolic process |
GO_2001137 | Biological process | positive regulation of endocytic recycling |
GO_0070292 | Biological process | N-acylphosphatidylethanolamine metabolic process |
GO_0005886 | Cellular component | plasma membrane |
GO_0031901 | Cellular component | early endosome membrane |
GO_0005829 | Cellular component | cytosol |
GO_0005765 | Cellular component | lysosomal membrane |
GO_0010314 | Molecular function | phosphatidylinositol-5-phosphate binding |
GO_0005547 | Molecular function | phosphatidylinositol-3,4,5-trisphosphate binding |
GO_0008970 | Molecular function | phospholipase A1 activity |
GO_0047498 | Molecular function | calcium-dependent phospholipase A2 activity |
GO_0005544 | Molecular function | calcium-dependent phospholipid binding |
GO_0005546 | Molecular function | phosphatidylinositol-4,5-bisphosphate binding |
GO_0032266 | Molecular function | phosphatidylinositol-3-phosphate binding |
GO_0080025 | Molecular function | phosphatidylinositol-3,5-bisphosphate binding |
GO_0016410 | Molecular function | N-acyltransferase activity |
GO_0005509 | Molecular function | calcium ion binding |
GO_0070273 | Molecular function | phosphatidylinositol-4-phosphate binding |
GO_0043325 | Molecular function | phosphatidylinositol-3,4-bisphosphate binding |
Gene name | PLA2G4E |
Protein name | Phospholipase A2 (EC 3.1.1.4) Cytosolic phospholipase A2 epsilon (cPLA2-epsilon) (EC 3.1.1.4) (Calcium-dependent N-acyltransferase) (Phospholipase A2 group IVE) Phospholipase A2 group IVE phospholipase A2 (EC 3.1.1.4) |
Synonyms | |
Description | FUNCTION: Calcium-dependent N-acyltransferase involved in the biosynthesis of N-acyl ethanolamines (NAEs) in the brain . Transfers the sn-1 fatty acyl chain of phosphatidylcholine (fatty acyl donor) to the amine group of phosphatidylethanolamine (fatty acyl acceptor) to generate N-acyl phosphatidylethanolamine (NAPE). Similarly can use plasmenylethanolamine as a fatty acyl acceptor to form N-acyl plasmenylethanolamine (N-Acyl-PlsEt). Both NAPE and N-Acyl-PlsEt can serve as precursors of bioactive NAEs like N-arachidonoyl phosphatidylethanolamine also called anandamide . Has weak phospholipase A2 and lysophospholipase activities (By similarity). Regulates intracellular membrane trafficking that requires modulation of membrane curvature as it occurs by enrichment in lysophospholipids. Promotes tubule formation involved in clathrin-independent endocytotic trafficking and cargo recycling (By similarity). . |
Accessions | ENST00000399518.3 [Q3MJ16-3] A0A8Q3SIH7 A0A8Q3SIE9 ENST00000696117.1 A0A8Q3WM91 ENST00000696115.1 A0A8Q3SIA2 ENST00000696112.1 ENST00000696114.1 Q3MJ16 A0A8Q3SIG9 ENST00000696116.1 ENST00000696118.1 |